↑ 薬物リストへ　← 戻る

Hmed-ides    (DrugBank: HMED-IdeS, IdeS)

2 diseases
告示番号疾患名（ページ内リンク）臨床試験数
64血栓性血小板減少性紫斑病0
221抗糸球体基底膜腎炎1

64. 血栓性血小板減少性紫斑病　［臨床試験数：74，薬物数：76（DrugBank：19），標的遺伝子数：15，標的パスウェイ数：57］
Searched query = "Thrombotic thrombocytopenic purpura", "TTP", "Upshaw-Schulman syndrome", "USS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 74 trial found

221. 抗糸球体基底膜腎炎　［臨床試験数：1，薬物数：3（DrugBank：1），標的遺伝子数：0，標的パスウェイ数：0］
Searched query = "Anti-glomerular basement membrane disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03157037
(ClinicalTrials.gov)		March 1, 201711/5/2017An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES)An Open-Label Phase II Study in Anti-GBM Disease (Goodpasture's Disease) With Adverse Renal Prognosis to Evaluate the Efficacy and Safety of IdeS --GOOD-IDESAnti-Glomerular Basement Membrane DiseaseBiological: HMed-IdeSMårten SegelmarkHansa Biopharma ABCompleted18 YearsN/AAll15Phase 2Austria;Czechia;Denmark;France;Sweden